Stay updated on Regeneron Press Releases

Sign up to get notified when there's something new on the Regeneron Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Regeneron Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    Adds a 2026 entry with the January 2, 2026 timestamp and the headline 'Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026', and updates the copyright year to 2026.
    Difference
    11%
    Check dated 2026-01-06T22:47:04.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Two new press releases were added: Dupixent approval in Japan for children aged 6 to 11 (Dec 23, 2025) and a presentation at the JP Morgan Healthcare Conference (Dec 22, 2025). Older items were removed: Regeneron Announces Investor Conference Presentations (Nov 3, 2025) and Dupixent Wins Prix Galien USA Best Biotechnology Product Award (Oct 31, 2025).
    Difference
    6%
    Check dated 2025-12-23T10:14:50.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Lynozyfic™ (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses, Supporting Rationale as a Potential Foundation in Frontline Treatment (December 7, 2025 4:30 PM EST). Removed Regeneron Reports Third Quarter 2025 Financial and Operating Results (October 28, 2025 6:30 AM EDT).
    Difference
    2%
    Check dated 2025-12-08T23:30:05.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added two new press releases to the list: TSRA-196 gene editing therapy with Tessera Therapeutics and Dupixent EU approval for CSU. Removed two older press releases dated Oct 17 and Oct 15, 2025.
    Difference
    6%
    Check dated 2025-12-01T20:29:48.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Added two new press releases on November 19, 2025 (FDA approval of EYLEA HD for macular edema following RVO and EU approval of Libtayo for adjuvant CSCC) and removed two older items (DB-OTO NEJM hearing/speech study and Libtayo CSCC US approval).
    Difference
    6%
    Check dated 2025-11-24T17:48:23.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    A new press release entry for November 13, 2025 was added to the Press Releases page, and an older press release listing was removed.
    Difference
    2%
    Check dated 2025-11-17T17:27:25.000Z thumbnail image

Stay in the know with updates to Regeneron Press Releases

Enter your email address, and we'll notify you when there's something new on the Regeneron Press Releases page.